July 28 (Reuters) - Laboratory Corporation of America
Holdings LH.N :
* LABCORP ANNOUNCES 2022 SECOND QUARTER RESULTS
* Q2 ADJUSTED EARNINGS PER SHARE $4.96
* Q2 EARNINGS PER SHARE $3.87
* Q2 REVENUE FELL 3.7 PERCENT TO $3.7 BILLION
* LABCORP - FULL-YEAR 2022 GUIDANCE ADJUSTED EPS RAISED TO
$19.00
TO $21.25
* Q2 EARNINGS PER SHARE VIEW $4.70, REVENUE VIEW $3.75
BILLION --
REFINITIV IBES DATA
* FY2022 EARNINGS PER SHARE VIEW $19.67 -- REFINITIV IBES
DATA
* LABCORP - DIAGNOSTICS REVENUE FOR QUARTER WAS $2.26
BILLION, A
DECREASE OF 4.7% FROM $2.37 BILLION IN Q2 OF 2021
* LABCORP - DRUG DEVELOPMENT REVENUE FOR QUARTER WAS $1.45
BILLION, A DECREASE OF 2.9% FROM $1.50 BILLION IN Q2 OF 2021
Source text for Eikon: ID:nBw2KM6H1a
Further company coverage: LH.N
((Reuters.Briefs@thomsonreuters.com;))